Table 1.
Citation | Type of cancer | Cell lines | Met dependence (Ccomplete, ++, partial. +independent, − |
---|---|---|---|
Najim et al. (2009)[8] | Central nervous system | Daoy (medulloblastoma) | ++ |
D-54 (glioma) | ++ | ||
Kokkinakis et al. (2001)[9] | Brain | D-54 | ++ |
SWB77 (glioblastoma) | ++ | ||
Daoy | ++ | ||
Willmann et al.(2015)[10] | Breast cancer | epithelial cell line MCF-10A | ++ |
Kano et al. (1982)[11] | Leukemia | Raji (Burkitt) | ++ |
BALL (B-cell) | ++ | ||
TALL (T-cell) | ++ | ||
MOLT-3 (T-cell) (−) | − | ||
MOLT 4B (T-cell) | ++ | ||
HL60 (promyelocytic ) | ++ | ||
K562 (chronic myelogenous leukemia in blastic crisis) | ++ | ||
Poirson-Bichat et al.(2000)[12] | Colon, lung, glioma | TC71-MA (colon) | ++ |
SCLC6 (small cell lung) | ++ | ||
SNB19 (glioma) | ++ | ||
Lu et al.(2000)[13] | Prostate | LNCaP (lymph node metastasis) | − |
PC-3 (distant metastasis) | ++ | ||
DU 145(distant metastasis) | + | ||
Guo et al.(1993)[14] | Prostate, lung, fibrosarcoma | PC3 | ++ |
SKLU-I (lung carcinoma) | ++ | ||
HT 1080 (fibrosarcoma) | ++ | ||
Mecham et al.(1983)[15] | Bladder, breast, cervical, colon, kidney, lung, prostate, fibrosarcoma, osteogenic sarcoma, glioblastoma, neuroblastoma | EJ (bladder) | ++ |
J82 (bladder) | ++ | ||
SK-BR-2-II (breast) | ++ | ||
MCF-7 (breast) | ++ | ||
HeLa (cervical) | ++ | ||
SK-CO-1 (colon) | ++ | ||
A498 (kidney) | ++ | ||
A2182 (lung) | ++ | ||
PC-3 | ++ | ||
8387 (fibrosarcoma) | ++ | ||
HT-1080 | ++ | ||
HOS (osteogenic sarcoma) | ++ | ||
Human neurological tumors | ++ | ||
A172 (glioblastoma) | ++ | ||
SK-N-SH (neuroblastoma) | ++ |